Variant report

Variant	nsv516798
Chromosome Location	chr12:1952990-1973384
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:57)
CpG islands
(count:427)
Chromatin interactive
region (count:17)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:57 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr12:1960290-1960578	IMR90	lung:	n/a	n/a
2	CTCF	chr12:1966944-1966981	LNCaP	prostate:	n/a	n/a
3	CTCF	chr12:1962700-1962850	GM12872	blood:	n/a	chr12:1962840-1962848
4	CTCF	chr12:1960540-1960690	AG10803	skin:	n/a	n/a
5	E2F4	chr12:1958924-1959064	MCF10A-Er-Src	breast:	n/a	n/a
6	E2F4	chr12:1968881-1969065	MCF10A-Er-Src	breast:	n/a	n/a
7	FOS	chr12:1968778-1969070	MCF10A-Er-Src	breast:	n/a	n/a
8	FOS	chr12:1961505-1961544	MCF10A-Er-Src	breast:	n/a	n/a
9	FOS	chr12:1968778-1969078	MCF10A-Er-Src	breast:	n/a	n/a
10	FOS	chr12:1968777-1969073	MCF10A-Er-Src	breast:	n/a	n/a
11	FOS	chr12:1960260-1960690	MCF10A-Er-Src	breast:	n/a	chr12:1960508-1960519
12	FOS	chr12:1960364-1960660	HUVEC	blood vessel:	n/a	chr12:1960508-1960519
13	FOS	chr12:1968763-1969077	MCF10A-Er-Src	breast:	n/a	n/a
14	FOS	chr12:1971920-1971943	MCF10A-Er-Src	breast:	n/a	n/a
15	FOS	chr12:1960240-1960731	MCF10A-Er-Src	breast:	n/a	chr12:1960508-1960519
16	FOS	chr12:1960227-1960683	MCF10A-Er-Src	breast:	n/a	chr12:1960508-1960519
17	FOS	chr12:1960240-1960701	MCF10A-Er-Src	breast:	n/a	chr12:1960508-1960519
18	FOSL2	chr12:1960283-1960747	SK-N-SH	brain:	n/a	n/a
19	FOXA1	chr12:1968871-1969216	T-47D	breast:	n/a	n/a
20	FOXA1	chr12:1971298-1971541	T-47D	breast:	n/a	n/a
21	FOXA1	chr12:1971224-1971579	T-47D	breast:	n/a	n/a
22	GATA2	chr12:1972860-1973198	SH-SY5Y	brain:	n/a	n/a
23	GATA3	chr12:1972819-1973121	SH-SY5Y	brain:	n/a	n/a
24	GATA3	chr12:1960335-1960780	SK-N-SH	brain:	n/a	n/a
25	GATA3	chr12:1968697-1969101	MCF-7	breast:	n/a	chr12:1969041-1969049
26	KAP1	chr12:1964381-1964816	HEK293	kidney:	n/a	n/a
27	KAP1	chr12:1968804-1969161	U2OS	brain:	n/a	n/a
28	MAX	chr12:1955748-1956842	NB4	blood:	n/a	n/a
29	MAX	chr12:1957941-1958303	NB4	blood:	n/a	n/a
30	MYC	chr12:1960521-1960716	H1-hESC	embryonic stem cell:	n/a	n/a
31	MYC	chr12:1960324-1960646	MCF10A-Er-Src	breast:	n/a	n/a
32	MYC	chr12:1957949-1958247	NB4	blood:	n/a	n/a
33	MYC	chr12:1968977-1969073	MCF10A-Er-Src	breast:	n/a	n/a
34	MYC	chr12:1960273-1960806	MCF10A-Er-Src	breast:	n/a	n/a
35	NFIC	chr12:1960192-1960898	SK-N-SH	brain:	n/a	n/a
36	PBX3	chr12:1960104-1960888	SK-N-SH	brain:	n/a	n/a
37	PBX3	chr12:1960202-1960841	SK-N-SH	brain:	n/a	n/a
38	POLR2A	chr12:1961279-1961319	MCF10A-Er-Src	breast:	n/a	n/a
39	POLR2A	chr12:1971947-1972045	GM12878	blood:	n/a	n/a
40	REST	chr12:1968785-1969093	PFSK-1	brain:	n/a	n/a
41	SETDB1	chr12:1964297-1964791	U2OS	brain:	n/a	n/a
42	SIN3AK20	chr12:1968445-1969287	MCF-7	breast:	n/a	n/a
43	SPI1	chr12:1961292-1961567	HL-60	blood:	n/a	n/a
44	SRF	chr12:1968679-1969205	MCF-7	breast:	n/a	n/a
45	STAT3	chr12:1960242-1960791	MCF10A-Er-Src	breast:	n/a	chr12:1960414-1960425
46	STAT3	chr12:1960244-1960635	MCF10A-Er-Src	breast:	n/a	chr12:1960414-1960425
47	STAT3	chr12:1968847-1969048	MCF10A-Er-Src	breast:	n/a	n/a
48	STAT3	chr12:1960251-1960701	MCF10A-Er-Src	breast:	n/a	chr12:1960414-1960425
49	STAT3	chr12:1960277-1960594	MCF10A-Er-Src	breast:	n/a	chr12:1960414-1960425
50	STAT3	chr12:1968820-1969070	MCF10A-Er-Src	breast:	n/a	n/a

(count:427 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:1970170-1970220	SK-N-MC	brain:	n/a
2	chr12:1973367-1973417	U87	brain:	n/a
3	chr12:1973237-1973287	HPAEpiC	pulmonary alveolar:	n/a
4	chr12:1963310-1963360	NHDF-neo	bronchial:	n/a
5	chr12:1973367-1973417	NH-A	brain:	n/a
6	chr12:1973208-1973258	PFSK-1	brain:	n/a
7	chr12:1973367-1973417	CMK	blood:	n/a
8	chr12:1973367-1973417	SAEC	small airway:	n/a
9	chr12:1973237-1973287	IMR90	lung:	fetal
10	chr12:1970170-1970220	GM12892	blood:	n/a
11	chr12:1973367-1973417	AG09309	skin:	n/a
12	chr12:1963310-1963360	HRPEpiC	eye:	n/a
13	chr12:1973237-1973287	Caco-2	colon:	n/a
14	chr12:1970170-1970220	HMEC	breast:	n/a
15	chr12:1973237-1973287	K562	blood:	n/a
16	chr12:1973340-1973390	HRE	kidney:	n/a
17	chr12:1963310-1963360	H1-hESC	embryonic stem cell:	embryo
18	chr12:1964603-1964653	HNPCEpiC	eye:	n/a
19	chr12:1973237-1973287	NT2-D1	testis:	n/a
20	chr12:1973367-1973417	AG10803	skin:	n/a
21	chr12:1973340-1973390	HAEpiC	amniotic membrane:	n/a
22	chr12:1973367-1973417	H1-hESC	embryonic stem cell:	embryo
23	chr12:1973367-1973417	PANC-1	pancreas:	n/a
24	chr12:1973208-1973258	NHBE	bronchial:	n/a
25	chr12:1964603-1964653	GM06990	blood:	n/a
26	chr12:1973237-1973287	GM06990	blood:	n/a
27	chr12:1964603-1964653	HPAEpiC	pulmonary alveolar:	n/a
28	chr12:1964603-1964653	SK-N-SH	brain:	n/a
29	chr12:1963310-1963360	AoSMC	blood vessel:	n/a
30	chr12:1973237-1973287	MCF10A-Er-Src	breast:	n/a
31	chr12:1963310-1963360	AG04449	skin:	fetal
32	chr12:1973237-1973287	AG09309	skin:	n/a
33	chr12:1964603-1964653	CMK	blood:	n/a
34	chr12:1973237-1973287	AG10803	skin:	n/a
35	chr12:1964603-1964653	HMEC	breast:	n/a
36	chr12:1973208-1973258	NH-A	brain:	n/a
37	chr12:1973340-1973390	HMEC	breast:	n/a
38	chr12:1964603-1964653	HEEpiC	esophagus:	n/a
39	chr12:1970170-1970220	SK-N-SH	brain:	n/a
40	chr12:1973340-1973390	K562	blood:	n/a
41	chr12:1973208-1973258	SK-N-MC	brain:	n/a
42	chr12:1970170-1970220	AG04450	lung:	fetal
43	chr12:1970170-1970220	ovcar-3	ovarian:	n/a
44	chr12:1973367-1973417	HRPEpiC	eye:	n/a
45	chr12:1963310-1963360	Hepatocyte	liver:	n/a
46	chr12:1964603-1964653	HAEpiC	amniotic membrane:	n/a
47	chr12:1970170-1970220	AG10803	skin:	n/a
48	chr12:1973237-1973287	BJ	skin:	n/a
49	chr12:1970170-1970220	Hepatocyte	liver:	n/a
50	chr12:1973208-1973258	IMR90	lung:	fetal

(count:17 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr12:1951607..1953524-chr12:2057455..2059714,2	MCF-7	breast:
2	chr12:1962397..1965390-chr12:1965944..1968413,2	K562	blood:
3	chr12:1905374..1907142-chr12:1951674..1953593,2	MCF-7	breast:
4	chr12:1954206..1956342-chr12:2043639..2046868,3	MCF-7	breast:
5	chr12:1945038..1946828-chr12:1971867..1974133,2	K562	blood:
6	chr12:1952274..1954241-chr12:1954730..1957718,2	K562	blood:
7	chr12:1968515..1969333-chr12:2041106..2041850,2	MCF-7	breast:
8	chr12:1968515..1969082-chr12:2040995..2041606,2	MCF-7	breast:
9	chr12:1953795..1956547-chr12:1969421..1971021,2	MCF-7	breast:
10	chr12:1956703..1959604-chr12:1963408..1966102,2	MCF-7	breast:
11	chr12:1953795..1956547-chr12:1969421..1971021,2	MCF-7	breast:
12	chr12:1947643..1951345-chr12:1957413..1959557,3	MCF-7	breast:
13	chr12:1952274..1954241-chr12:1954730..1957718,2	K562	blood:
14	chr12:1949995..1951546-chr12:1955088..1956789,2	MCF-7	breast:
15	chr12:1956703..1959604-chr12:1963408..1966102,2	MCF-7	breast:
16	chr12:1950335..1952773-chr12:1969860..1971374,2	MCF-7	breast:
17	chr12:1959456..1961016-chr12:1962388..1965205,2	MCF-7	breast:

No data

Variant related genes	Relation type
CACNA2D4	TF binding region
CACNA2D4	CpG island
ENSG00000151062	chromatin interactions
ENSG00000235049	chromatin interactions

Extended variants
information (count: 774 )
Associated
traits (count: 82 )

Variant overlapped rSNPs/rCNVs (count:774 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7967890	chr12:1952990-1952991	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs138332898	chr12:1953001-1953002	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs149652666	chr12:1953012-1953013	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs569574645	chr12:1953028-1953029	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs369394804	chr12:1953065-1953066	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs137901010	chr12:1953092-1953093	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs373152765	chr12:1953111-1953112	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs578259513	chr12:1953175-1953176	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs79997159	chr12:1953196-1953197	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs546385062	chr12:1953240-1953241	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs554409931	chr12:1953255-1953256	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs572559627	chr12:1953262-1953263	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs543692463	chr12:1953268-1953269	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs142433486	chr12:1953314-1953315	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs114732984	chr12:1953316-1953317	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs185132387	chr12:1953366-1953367	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs75813147	chr12:1953424-1953425	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs564934466	chr12:1953432-1953433	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs538300749	chr12:1953466-1953467	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs78771292	chr12:1953478-1953479	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs547251328	chr12:1953488-1953489	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs565556098	chr12:1953506-1953507	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs145975610	chr12:1953512-1953513	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs370778755	chr12:1953522-1953523	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs189074544	chr12:1953525-1953526	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs374107821	chr12:1953526-1953527	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs118015560	chr12:1953544-1953545	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs536736418	chr12:1953554-1953555	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs367689303	chr12:1953561-1953562	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs370228940	chr12:1953598-1953599	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs558630219	chr12:1953616-1953617	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs374500884	chr12:1953630-1953631	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs201050373	chr12:1953631-1953632	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs71454844	chr12:1953632-1953633	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs539350541	chr12:1953641-1953642	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs200749936	chr12:1953664-1953665	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs199886801	chr12:1953673-1953674	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs536886620	chr12:1953719-1953720	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs200276938	chr12:1953720-1953721	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs554855656	chr12:1953763-1953764	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs114348789	chr12:1953781-1953782	Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs114592404	chr12:1953844-1953845	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs74059401	chr12:1953846-1953847	Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs576794012	chr12:1953849-1953850	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs2286375	chr12:1953866-1953867	Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs375125223	chr12:1953868-1953869	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs537224722	chr12:1953921-1953922	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs559628897	chr12:1953931-1953932	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs529929374	chr12:1953998-1953999	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs548404008	chr12:1954009-1954010	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:82)

Disease	PMID	Source
Myelofibrosis	22110671	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
Glaucoma	21310917	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Malignant peripheral nerve sheath tumor	19844265	CNVD
Squamous cell cancer	19607727	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Mental retardation	17847001	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
abnormal development	18461090	CNVD
Ovarian cancer	20844748	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Medulloblastoma	16968546	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Breast cancer	22032731	CNVD
Cancer	21183584	CNVD
Myxofibrosarcoma	16751306	CNVD
Non-small cell lung cancer	21829676	CNVD
Ovarian neoplasms	16753589	CNVD
Prostate cancer	21965145	CNVD
Acute myeloid leukemia	16864856	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Disorders of sex development	21048976	CNVD
Glioblastoma multiforme	21080181	CNVD
Liposarcoma	21253554	CNVD
Prostate cancer	19156837	CNVD
Emphysema	19352772	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Malignant germ cell tumour	17285132	CNVD
Melanoma	18172304	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Wilms tumour	21544195	CNVD
Squamous cell cancer	21044232	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Breast cancer	21264507	CNVD
Cancer	16751803	CNVD
Testicular cancer	18059402	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Seminomas	18059402	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Testicular germ cell tumor	18059402	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Breast cancer	21364760	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21509527	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21785460	CNVD
Ovarian cancer	21720365	CNVD
Myelodysplastic syndrome	21251322	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
small cell lung cancer	20016488	CNVD
Cancer	20164919	CNVD
Urothelial carcinoma	21177765	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Bipolar disorder	22488967	CNVD

Chromatin state (count:72 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:1940800-1953400	Weak transcription	H9 Cell Line	embryonic stem cell
2	chr12:1947200-1953400	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
3	chr12:1948600-1954000	Enhancers	Primary hematopoietic stem cells short term culture	blood
4	chr12:1950200-1953400	Weak transcription	iPS-15b Cell Line	embryonic stem cell
5	chr12:1950400-1953400	Weak transcription	HUES6 Cell Line	embryonic stem cell
6	chr12:1950400-1953600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
7	chr12:1950400-1953800	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
8	chr12:1950600-1953600	Weak transcription	Brain Germinal Matrix	brain
9	chr12:1951600-1956000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
10	chr12:1952000-1955000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
11	chr12:1952600-1953400	Enhancers	HUES48 Cell Line	embryonic stem cell
12	chr12:1952600-1953400	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
13	chr12:1952800-1953200	Weak transcription	H1 Cell Line	embryonic stem cell
14	chr12:1952800-1953200	Weak transcription	Fetal Brain Female	brain
15	chr12:1953200-1954600	Enhancers	H1 Cell Line	embryonic stem cell
16	chr12:1953200-1955400	Enhancers	Fetal Brain Female	brain
17	chr12:1953400-1953600	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
18	chr12:1953400-1953600	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
19	chr12:1953400-1954200	Enhancers	H9 Cell Line	embryonic stem cell
20	chr12:1953400-1954200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
21	chr12:1953400-1954200	Enhancers	iPS-15b Cell Line	embryonic stem cell
22	chr12:1953400-1954200	Enhancers	iPS-18 Cell Line	embryonic stem cell
23	chr12:1953400-1954400	Enhancers	HUES6 Cell Line	embryonic stem cell
24	chr12:1953400-1954800	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
25	chr12:1953400-1955200	Enhancers	Fetal Brain Male	brain
26	chr12:1953600-1953800	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
27	chr12:1953600-1953800	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
28	chr12:1953600-1954000	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
29	chr12:1953600-1954200	Enhancers	HUES64 Cell Line	embryonic stem cell
30	chr12:1953600-1954400	Enhancers	ES-I3 Cell Line	embryonic stem cell
31	chr12:1953600-1954400	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
32	chr12:1953600-1954400	Bivalent Enhancer	Fetal Stomach	stomach
33	chr12:1953600-1954800	Enhancers	Brain Germinal Matrix	brain
34	chr12:1953800-1954400	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
35	chr12:1953800-1954400	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
36	chr12:1954000-1954400	Enhancers	HUES48 Cell Line	embryonic stem cell
37	chr12:1955000-1957400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
38	chr12:1955200-1960000	Weak transcription	Fetal Brain Male	brain
39	chr12:1955400-1956200	Weak transcription	Fetal Brain Female	brain
40	chr12:1956000-1957400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
41	chr12:1956200-1956400	Enhancers	Fetal Brain Female	brain
42	chr12:1956400-1956600	Weak transcription	Fetal Brain Female	brain
43	chr12:1957200-1957600	Bivalent Enhancer	HepG2	liver
44	chr12:1957400-1957600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
45	chr12:1957400-1958400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
46	chr12:1957600-1958400	Enhancers	HepG2	liver
47	chr12:1958200-1962800	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
48	chr12:1960000-1960600	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
49	chr12:1960000-1961000	Enhancers	Osteobl	bone
50	chr12:1960000-1962000	Enhancers	Fetal Brain Male	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links